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 9 
Abstract 10 
The robustness of the Peptide Reversed Phase Chromatography (RPC) Column Characterisation 11 
Protocol was evaluated using reduced factorial design, to ascertain the degree of control required 12 
for parameters including temperature, flow rate, dwell volume, a systematic shift in the gradient, 13 
amount of formic acid in the aqueous and organic, pH of the ammonium formate and amount of 14 
acetonitrile in the strong solvent (%MeCN). All levels were deemed acceptable within reasonable 15 
tolerances except the %MeCN in the strong solvent, where a loss of MeCN resulted in an 16 
unacceptable variation. Mitigations have been introduced to ensure the integrity of the data to 17 
allow RPC columns to be characterised using peptides as probes, with the definitive protocol 18 
described. In addition, the instrument and column batch to batch variability were assessed with 19 
good reproducibility.  20 
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 25 
1 Introduction 26 
The selection of appropriate stationary phases is a key element of method development, however, 27 
with the plethora of phases available from many different column manufacturers, it is difficult to 28 
make a rational decision as to which column to start with. For small molecules, there are various 29 
strategies including the Tanaka and its extended protocol, Snyder’s Hydrophobic Subtraction Model 30 
and Lesellier’s Linear Subtraction Energy Relationships (LSER) which have characterised reversed 31 
phase (RP) stationary phases, with the results available in databases which are free to access [1-5]. 32 
These databases allow the end user to establish which phases are chromatographically different for 33 
a diverse range of phases used for method development purposes, or alternatively, select phases 34 
which are chromatographically similar, in order to select “back-up” columns.  35 
Until recently, there has not been a corresponding characterisation protocol for RP columns suitable 36 
for peptide separations, however, the Peptide RPC Column Characterisation Protocol was developed 37 
to address this deficiency [6]. A range of 26 specifically designed peptides with different physico-38 
chemical properties were synthesised to assess prominent interactions such as hydrophobicity, 39 
hydrogen bonding, electrostatic interactions and aromatic character as well as reflect typical paths 40 
for degradation of peptides. These 26 peptides were evaluated on 14 stationary phases that 41 
possessed different properties based on prior knowledge of the column chemistry using gradient 42 
chromatography at low and intermediate pH. Selectivity was measured using the difference in 43 
normalised retention (Δtg*), where a total of 66 delta values were produced to probe different types 44 
of interactions which were critically assessed using principal component analysis (PCA). The mobile 45 
phases selected were formic acid (~pH 2.5) and ammonium formate at (~pH 6.45, native pH) to 46 
evaluate the purer interactions of the stationary phase. The rationale for mobile phase selection can 47 
be observed in reference 6. The stationary phases were categorised into three distinct groupings to 48 
describe the prominent interactions; neutral (phases which possess a high degree of ligand density 49 
and / or end capping), negative / polar (phases which either contain a negatively charged moiety in 50 
the ligand, capable of silanophilic interactions due to a light bonding / lack of end capping, or 51 
functionalities which are capable of forming polar interactions such as hydrogen bonding) and 52 
positive character(phases which contain a positively charged moiety). The total of peptides required 53 
was reduced from 26 to 11 which generated 11 delta values to describe changes in positive / 54 
negative charge, hydrophobicity, phenolic character, aromatic character as well as steric changes, 55 
racemisation, deamidation and oxidation (Table 1 and Table 2). A smaller study was conducted to 56 
observe the effect of TFA instead of formic acid as the low pH additive, as TFA is quite frequently 57 
used for peptide analysis. The resulting data caused the distinct categories produced via the formic 58 
acid / ammonium formate biplot to lose their structure which suggests a loss of information when 59 
using TFA. This is as hypothesised as TFA acts as an ion pair therefore the character of the stationary 60 
phase is of less importance, thus emphasising the necessity to conduct a column characterisation 61 
protocol using an appropriate additive like formic acid. An iterative study was conducted which 62 
appraised the 66 delta values to determine if the total number could be reduced whilst still fully 63 
describing the stationary phases. 64 
In order for the Peptide RPC Column Characterisation protocol to be truly valuable, the robustness 65 
must be considered [7]. Robustness is defined by the ICH guidelines as “a measure of its capacity to 66 
remain unaffected by small but deliberate variations in method parameters and provides an 67 
indication of its reliability during normal usage” [8,9]. The robustness of the protocol was assessed 68 
using a reduced factorial design often referred to as a DoE (design of experiments), which is one of 69 
the most commonly used tools for the assessment of robustness both within academia and the 70 
pharmaceutical industry. In this methodology, small systematic changes reflecting the expected 71 
experimental errors associated with the procedure are explored [9-11]. Alternative methods such as 72 
one factor at a time (OFAT) could be used, which looks to vary one variable whilst maintaining all 73 
other parameters of interest. However, it can often prove more resource intensive (i.e. time, 74 
materials etc) and can fail to estimate the interaction between different variables. A considerable 75 
amount of information can be derived from DoE with statistical significance, which cannot be 76 
obtained via the OFAT approach [12]. The 11 peptide delta values were used as responses to create 77 
the DoE models which highlighted the degree of deviation the systematic changes created from the 78 
nominal centre point i.e. the original method conditions. This data informs what variable(s) are 79 
statistically significant and their practical relevance on the result, thus highlighting what operating 80 
parameters must be carefully controlled in order to maintain a robust methodology. It is integral 81 
that the robustness of the procedure be considered before a larger set of stationary phases are 82 
evaluated which can be included into a column characterisation database for individuals to rationally 83 
select stationary phases for peptide / protein separations. A similar approach was used to assess the 84 
robustness of the Tanaka and extended protocols in order to ensure the integrity of the column 85 
database [10].  86 
This paper aims to gain a greater understanding of the crucial factors which could impact on method 87 
robustness, which not only includes performing a DoE on LC parameters used in the protocol, but 88 
also establishes the robustness of mobile phase pH switching and sample load. Finally, the practical 89 
operating limits of the LC parameters used in the protocol will be established in order to maintain 90 
acceptable repeatability and reliability of the integrity of the peptide-based column characterisation 91 
database. This paper is part of a series of articles which are designed to interrogate the factors which 92 
influence the peptide separation system, where firstly the stationary phases were evaluated before 93 
investigating the effect of different mobile phase additives to aid the chromatographer in making 94 
rational decisions relating to their chromatographic separation.     95 
 96 
2 Experimental 97 
2.1 Chemicals, Reagents and Instrumentation 98 
All chemicals used are described in reference 6. Unless otherwise stated all LC separations were 99 
performed on a Shimadzu Nexera X2 UHPLC system where modules were previously described [6]. 100 
The base sequence for each peptide can be located in Table 2, and further description of the peptide 101 
probes described in reference 6. 102 
 103 
2.2 Factorial Design 104 
The Peptide RPC Column Characterisation protocol conditions were described in reference 6. The 105 
new test mixtures with each specific column load can be found in Table 3. Each test mixture 106 
contained the two peptides required to calculate a precise delta value. This sometimes meant that 107 
there was duplication of peptides in multiple test mixtures. This was to ensure the delta values were 108 
well described and increase method robustness as small degrees of retention drift could impact on 109 
subtle interactions such as racemisation. The peptides selected were based on the iterative process 110 
of elimination conducted within reference 6, and contain both subtle and more significant changes 111 
to evaluate common degradation and specific interactions to describe the column for 112 
characterisation. The delta values, which are a measure of the selectivity in gradient elution, are 113 
used as the input for the DoE. 114 
The factors evaluated in the DoE were summarised in Table 4, including the different ±1 levels. The 115 
factors investigated were selected as the most likely sources of error, where the levels were 116 
ascertained to reflect the random variation one could expect (i.e. at least 3x the expected standard 117 
deviation). Error propagation calculations based on instrument specifications and qualification data 118 
were employed in the estimation of standard deviation [13]. 119 
Modde Pro software (see Section 2.4) was employed to create and evaluate reduced factorial 120 
designs, which utilised eight methods with various +1 or -1 levels for the different variables, and 121 
three repeat methods for the central nominal conditions to ascertain the reproducibility of the 122 
procedure (Tables 5 and 6 for formic acid and ammonium formate gradients, respectively). Different 123 
batches of solvents were produced for the nominal conditions. The software created a random run 124 
order to remove any bias within the results. 125 
 126 
2.3 Instrument Variability 127 
Instrumental variability was compared between three additional LC instruments; Waters H-Class, 128 
Waters I-Class (Milford, Ma, USA) and Agilent 1290 binary system (Waldbronn, Germany) using the 129 
same batches of mobile and stationary phase. The dwell volumes varied between 300 and 700 µL. 130 
The Waters instruments were controlled by Empower 3 (Feature release 3) whilst the Agilent 131 
configuration was controlled by OpenLab CDS (Chemstation C.01.07 SR4). 132 
 133 
2.4 Stationary Phases 134 
The Peptide RPC Column Characterisation protocol was developed using 14 diverse stationary 135 
phases [6] and a standardised column format of 150 x 2.1 mm. All columns were new as supplied by 136 
the manufacturer. A Phenomenex Kinetex Evo C18 (150 x 2.1 mm, 100 Å, 2.6 µm) was used for the 137 
reduced factorial design experiments whilst the instrument variation was performed on a Waters 138 
Acquity HSS C18 (150 x 2.1 mm, 130 Å, 1.8 µm). Column batch to batch variability was assessed on 139 
six different batches of Ascentis Express C18 with six differing base silicas and four differing silanes 140 
(150 x 2.1 mm, 90 Å, 2.7 µm). Loading studies were performed on a Phenomenex Kinetex C18 (150 x 141 
2.1 mm, 100 Å, 2.6 µm). The peak apex of a water injection was used as the dead time marker for 142 
each column [14].  143 
 144 
2.5 Software and Calculations 145 
Principal Component Analysis (PCA) was performed using SIMCA (Version 14.1, Umetrics, Umeå, 146 
Sweden) and Origin (Version OriginPro 2016, OriginLab, Northampton, MA, USA). The variables 147 
within the PCA were all autoscaled, in order to give each variable the same importance. Reduced 148 
factorial design was performed using Modde Pro (Version 12.0.1. Umetrics, Umeå, Sweden). The net 149 
charges of the peptide probes were calculated at both pH 2.5 and 6.45 using General Protein/Mass 150 
Analysis for Windows (GPMAW) software (Version 9.51, Lighthouse Data, Odense, Denmark). 151 
 152 
3 Results and Discussion 153 
3.1 Principle Component Analysis and Factorial Design 154 
The robustness of each delta value (Table 4) was assessed by fitting a first order polynomial model to 155 
the data obtained for the formic acid and ammonium formate designs (Table 5 and 6). The typical 156 
Δtg and Δtg* values obtained on the Kinetex Evo C18 can be seen in Table 1 under the nominal centre 157 
point conditions.  158 
The quality of the model is measured using a regression coefficient from fitting the model (R2) and 159 
one from a cross validation of the model (Q2) [11,15]. For a good model both values are close to 1. 160 
However, in a robustness evaluation an ideal outcome would be a poor model, i.e. low R2 and Q2 161 
values. The effect of a ±1 change of the different factors should, for a robust methodology, 162 
correspond to the experimental noise at nominal conditions.  163 
The average R2 and Q2 for the delta values in formic acid were 0.761 (standard deviation SD 0.208) 164 
and -0.133 (SD 0.151), respectively, whilst for the ammonium formate delta values, R2 and Q2 165 
measured 0.750 (SD 0.080) and -0.200 (SD 0.000), respectively. The centre point experiments (N9-166 
11) provide an indication into the reproducibility of the procedure, where the average difference for 167 
the delta probes was 0.001 (ranged from 0.000 to 0.004 for the relevant delta values). The result 168 
gives an early indication that the Peptide RPC Column Characterisation protocol should be robust.  169 
The method robustness can be evaluated further by comparing coefficient plots which evaluates the 170 
individual effect of each parameter on the robustness (Fig. 1 and 2). Each variable was scaled and 171 
centred in the coefficient plots, so that they were comparable. The height of the bar gives the 172 
degree of the effect whilst the error bar indicates the 95% confidence interval which highlights 173 
statistically significant parameters when the error bar does not cross zero.  174 
 175 
3.1.1 Temperature 176 
Temperature had no discernible effect on any of the responses in ammonium formate and the 177 
majority in formic acid, however, there was a statistical response for Δ(8a,1) and Δ(16,13) in formic 178 
acid. The height of the bars however would indicate that the practical significance on these two 179 
delta results would be minimal. Although for these probes it has a minimal effect, it is recommended 180 
that the actual temperature of the column is determined, as it is known that the column oven design 181 
and even column position within the oven can change the actual temperature within the column.  182 
This can be achieved by injecting caprylophenone (detection at 250 nm) onto a column using a 183 
premixed mobile phase of MeCN/H2O (45:55 w/w) to eliminate instrument to instrument %MeCN 184 
variations. The column oven temperature is changed in 5 °C intervals over the range 30-60 °C. The 185 
same column is then tested by immersing it in a water bath with 30 cm of 0.12 mm tubing prior to 186 
the column for thermostating. This is then assumed to be an accurate measure of the temperature 187 
of the column. The temperature of the water bath should be determined using a calibrated / 188 
certified thermometer with an appropriate accuracy e.g. ±0.5 °C between 30 to 60 °C.  189 
The sample is injected at 30 to 60 °C in 5 °C intervals in order to construct a plot (retention time – 190 
system dead time) vs. temperature plot in order to determine any deviation in temperature for the 191 
LC system (i.e. ΔT at a certain retention time).  System dead time is subtracted from the retention 192 
time to allow for comparison between the ovens and is determined by the retention time of water 193 
(detection at 215 nm), where the column is replaced with a union. This procedure should be 194 
followed for any new type of column oven design, and once the actual temperature of the column is 195 
determined, the Peptide RPC Column Characterisation Protocol can be adapted to compensate for 196 
any deviation in temperature. 197 
 198 
3.1.2 Systematic Shift in the Gradient Composition 199 
The responses in formic acid and ammonium formate were all unaffected by the systematic shift in 200 
the gradient. This systematic shift in the gradient assumes the same degree of error will apply across 201 
the length of the gradient.  202 
 203 
3.1.3 Flow rate 204 
A change of flow rate also corresponds to a change in gradient slope. Flow rate only presented a 205 
small statistical response for Δ(9,1) in formic acid, whilst all other responses in both ammonium 206 
formate and formic acid were unaffected. Similar to temperature, the actual practical effect of this 207 
variable would be quite minimal, thus this parameter can be assumed to be robust within the 208 
methodology.  209 
 210 
3.1.4 Dwell Volume 211 
Dwell volume was statistically insignificant for all responses in either mobile phase, indicating this 212 
variable does not impact on the robustness of either the formic acid or ammonium formate 213 
gradient. This is to a large extent due to the normalisation of the retention times which removes the 214 
effect of dwell volume, allowing direct comparison between different instrumentation. The dwell 215 
volume range selected for evaluation (100 - 500 µL) should cover UHPLC instrumentation. 216 
 217 
3.1.5 Amount of Formic Acid 218 
Differences in formic acid levels could impact on the robustness of the protocol as different levels 219 
would result in a different pH which would affect the overall net charge on the peptides. However, 220 
differences in formic acid volume were observed to be insignificant, the Δ(9,1) and Δ(16,13) values 221 
exhibited a very small statistical significance but this was deemed to be of little practical relevance. It 222 
is recommended though that formic acid volumes should be dispensed volumetrically from a pre-223 
calibrated pipette which is checked each time a solvent is prepared to ensure the integrity of the 224 
chromatographic results.    225 
 226 
3.1.6 Ammonium Formate Stock Solution pH 227 
The stationary phase environment at intermediate pH is somewhat unpredictable due to the range 228 
of pKa values for the residual silanols [16,17]. It is believed the majority of silanols should be ionised 229 
at pH 6.45 (the native pH of ammonium formate), however, this uncertainty can potentially lead to a 230 
greater degree of variation in results and hence can contribute to the lack of robustness. The 231 
ammonium formate can also be a source of error, where the age of the buffer, its storage 232 
environment and its resultant pH range were investigated. The pH was measured for 16 different 233 
200 mM solutions where the average pH was 6.45 (SD 0.03). The levels in the DoE (pH 6.45 ±0.06) 234 
were set based on a 99% CI based on triplicate determinations of the pH. The age of the ammonium 235 
formate did not appear to greatly affect the overall pH of the solution, where the pH measured was 236 
within the range tested in the DoE. There was, however, a change in pH based on salts which were 237 
inappropriately stored, which resulted in a lower pH for a poorly capped container which indicates a 238 
loss of ammonia. This could impact on the degree of silanol ionisation and hence affect retention 239 
and the delta values. Ideally, the formate salt should be stored in a desiccator to reduce water 240 
uptake and firmly replacing the cap should reduce the risk of ammonia loss. 241 
The responses in ammonium formate were all stable within the upper and lower pH limits in the 242 
DoE, with no statistical significance. The pH of the stock buffer solution should be measured using 243 
appropriately calibrated standards to ensure the pH is within this range to ensure the integrity of the 244 
protocol. It is also advised that if the ammonium formate exhibits any considerable signs of 245 
hygroscopicity in addition to changes in pH then it should not be used.    246 
To avoid microbial growth which could contaminate the LC system and potentially block the column 247 
inlet frit, causing split peaks and higher back pressures, it is recommended to limit the storage of 248 
stock buffer solution to 4 months at 5 °C.  249 
 250 
3.1.7 MeCN Composition in the B Solvent 251 
The selectivity of Δ(3,1), Δ(9,1), Δ(10,9) and Δ(24,13) were particularly susceptible to the change in 252 
acetonitrile content in the B solvent in the ammonium formate gradients. The effect was actually 253 
significant enough that it would have practical relevance, unlike previous variables, and thus 254 
warranted further investigation.  255 
As described in the previous publication which defined the Peptide RPC Column Characterisation 256 
Protocol, PCA is used in order to visualise similarities and differences between delta values and 257 
columns in so called biplots [3,18]. The delta values for the ammonium formate and formic acid 258 
DoE’s were included in a PCA to evaluate the robustness of the method on the protocols ability to 259 
differentiate differing stationary phases from one another and to see what limits of the proposed 260 
MeCN levels had on the integrity of the results. As can be seen in the resulting biplot (Fig. 3), most of 261 
the DoE runs are clustered close to the origin except for a small subset of runs which are located 262 
further down in the lower left quadrant. Further evaluation indicated the subset was pulled away by 263 
the -1 level for the MeCN content in the B solvent.  264 
A loss of MeCN could possibly be expected by evaporation of solvent in the mobile phase reservoirs 265 
over a period of time. An evaporation study was therefore performed to ascertain what could be 266 
reasonably lost via the LC solvent caps. An Agilent Valve cap (Waldbronn, Germany) and a SCAT 267 
safety cap (Mörfelden-Walldorf, Germany) were compared against a closed cap used for solvent 268 
storage. There was 0.00% loss in weight for the closed cap over 30 days, suggesting acetonitrile is 269 
not lost during storage, however, it was calculated that losses of 0.04 and 0.03% for the Agilent and 270 
SCAT caps, respectively, could be expected per day, which could prove practically problematic.  271 
In order to combat this, the approach was taken to change the B solvent from 20 mM ammonium 272 
formate in MeCN/H2O (80:20 w/w) to 100% MeCN. The gradient was adjusted accordingly to achieve 273 
the same volume fraction of MeCN and compared against the original method, with similar 274 
chromatographic results, regardless of the reduced buffer concentration in the B solvent (the 275 
ammonium formate concentration is reduced from 18 to 12 mM during the part of the gradient 276 
where peptides typically elute).  277 
 278 
3.2 Instrument Variability 279 
The ability to successfully translate LC methodologies between differing LC instrumentation is 280 
extremely important for the widespread acceptance of the protocol. This is particularly important 281 
with respect to gradient chromatography where the contribution of column volume and dwell 282 
volume has been shown to cause considerable selectivity differences [19].   283 
The three peptide mixtures were injected onto an Acquity HSS C18 column on three different 284 
instruments, Agilent 1290, Waters Acquity H- and I-class ranging in dwell volume between 300 and 285 
700 µL, which was larger than the range assessed within the DoE. The same batches of mobile 286 
phases and column were used on all the comparisons to remove any variation attributed to mobile 287 
phase preparation differences and understand the instrument contribution to the study.  288 
The delta values were recorded for each instrument and compared, after which the data was 289 
analysed by PCA and placed in the biplot (Fig. 3). The three instruments are circled within a 95% 290 
confidence limit.  This variation is comparable to what can be expected from the DoE thus indicating 291 
results obtained on different type of instruments should be comparable.  292 
 293 
3.3 Column Batch to Batch Variability  294 
The column batch to batch variability was assessed using six Ascentis Express C18 columns. All 295 
columns differed by silica, whilst three columns contained the same batch of silane with three 296 
additional silane batches used for the remaining columns.  297 
All batch to batch columns were tested using the new protocol with the reduced number of probes 298 
(i.e. removal of probes susceptible to changes in MeCN) on the same occasion and mobile phases to 299 
remove their contribution to any variability. 300 
The batch to batch observations can be seen encircled within the biplot (Fig. 4) where the scatter 301 
seen is due to the batch to batch variation as the data was collected on the same day using the same 302 
instrument and solvents to eliminate their contribution from the results. The results are also in 303 
keeping with previous batch to batch studies performed on other columns using various protocols 304 
[9,20-26]. This highlights that any deviation between columns within the biplot is caused by 305 
selectivity differences, thus it is feasible to distinguish stationary phases which are 306 
chromatographically similar or dissimilar using this approach. 307 
 308 
3.4 Slow Equilibration  309 
Slow equilibration of certain RP materials when changing from intermediate to low pH has been well 310 
documented by Snyder et al. It is exhibited by a steady retention time drift on changing the mobile 311 
phase pH. It is believed that approximately 40% of all commercially available stationary phases 312 
exhibited some form of slow equilibration [27]. The exact mechanism for this phenomenon is not 313 
known, but it is speculated that with the advent of modern silica with low surface charge, changes in 314 
pH can require significant time to re-equilibrate which is displayed as retention drift for ionisable 315 
species.    316 
A selection of C18 type phases were assessed using the peptides as probes to determine any 317 
practical constraints for the Peptide RPC Column Characterisation protocol, which utilises both low 318 
and intermediate pH. 319 
The peptide test mixture was repeatedly injected on a C18 stationary phase using the formic acid 320 
gradient conditions with consistent results (Fig. 5(A)). The phase was then exposed to the 321 
ammonium formate gradient conditions, which saw quick equilibration of the peptide mixture within 322 
duplicate injections, suggesting consistent results can be achieved when moving from low to 323 
intermediate conditions.  324 
However, when the same column was then re-exposed to the formic acid gradient, it failed to yield 325 
results comparable to those prior to exposure to intermediate pH (slow reduction in retention – see 326 
Fig. 5(B)). The retention times for all peaks had increased, but were consistently decreasing in 327 
retention between injections.  328 
Literature has suggested static equilibration can restore a column which exhibits slow equilibration 329 
[27-29], however, even an overnight static equilibration in low pH conditions failed to restore this 330 
stationary phase to its original chromatographic retentivity (Fig. 5(C)). 331 
This phenomenon is not exclusive to just formic acid, but between any switch from intermediate or 332 
high pH to low pH for ionisable species. The issue would also not be corrected with the use of TFA, as 333 
the ion pairing effect of this additive would mean dedicated columns would be required which 334 
would be impractical for column characterisation [30]. Although there are stationary phases which 335 
have been devised to combat this slow equilibration issue such as the Acquity CSH range of phases 336 
[31], there are a number of commercially available columns which do exhibit this phenomenon. As 337 
such, the decision was made to characterise each stationary phase initially using the formic acid 338 
gradient, before testing at intermediate pH using ammonium formate in order to avoid any 339 
detrimental retention drifts or the necessity for excessive equilibration times.  340 
 341 
3.5 Loadability 342 
Chromatographic efficiency can be highly susceptible to analyte overloading which contributes to 343 
poor peak shape, especially for ionisable species. The permissible load before chromatographic 344 
performance is affected is often substantially lower for peptides and protein separations [31]. A 345 
significant amount of literature is available on the subject of loadability of basic species, and 346 
rationalising overloading effects [32-34]. 347 
A stock solution of [L-Asp3]-Bovine GLP-2 (1-15) (1 mg/mL) underwent a series of dilutions using 348 
DMSO/H2O (80:20 v/v). Each solution was reproducibly injected onto the Kinetex Evo C18 (150 x 2.1 349 
mm, 2.6 µm) using the formic acid gradient chromatographic conditions. The low ionic strength of 350 
formic acid is a worst-case scenario; thus, it was selected to observe the effects of loadability and 351 
overloading. 352 
Eight dilutions were made in total (four shown for simplicity in Fig. 6) with the resulting 353 
chromatograms overlaid. The hydrophilic peptide, which has a net charge of +1.2 at pH 2.5, 354 
displayed the characteristic “shark fin” peak shape with increased load for a positively charged 355 
species in acidic conditions i.e. a typical right-angled front and extreme tailing. The apex of the peak 356 
is used to measure the retention time decrease with increased load on the column and as such, 357 
would affect the normalised retention times used to calculate delta values. The degree to which this 358 
effect occurs could be different for each peptide, hence the load for each peptide must be well 359 
described in order to maintain consistent delta values. The peak shape for this study is not of critical 360 
concern as it is the retention time which must be consistent, hence the necessity to keep the load 361 
constant. When devising chromatographic methods, it would be crucial to select mobile phases 362 
which can provide better peak shape, with the biopharmaceutical industry typically utilising 363 
phosphate salt based systems.   364 
The loading profile could also be different depending on the type of stationary phase used. For 365 
example, the Acquity CSH range of stationary phases were optimised to provide improved peak 366 
shape and efficiency for basic species to provide linear isotherms, rather than typical Langmuir 367 
isotherm (Fig. 6). Similar to the slow equilibration effect, overloading behaviour is thought to be due 368 
to variations in the surface charge, where the balanced surface charge of the CSH range counteracts 369 
that issue to produce symmetrical, efficient peaks [31].   370 
The sample solubility also is critical when it comes to sample load. The net charge of the hydrophilic 371 
peptides at pH 2.5 and 6.5 are +1.1 to +1.2 and -4.7 to -3.7, respectively. The hydrophobic peptides 372 
have a net charge of +2.2 at pH 2.5, whilst at pH 6.5 the net charge is 0.0. A pI of 0.0 may highlight 373 
potential solubility problems and the possibility of precipitation and clogging of the inlet frit. 374 
Pressure increases and decreased column performance were observed after prolonged exposure to 375 
intermediate pH conditions. Replacement of the inlet frit and scanning electron microscopy proved 376 
that particulates had been deposited onto the frit. Hence, in order to minimise the likelihood of this 377 
happening the load of the peptides was reduced and inline filters installed between the injector and 378 
the column.  379 
 380 
3.6 Mitigating Action: Adjustment of the Peptide RPC Column Characterisation Protocol 381 
The ideal scenario from the reduced factorial design is to find that none of the parameters assessed 382 
are statistically or practically relevant. However, if there are parameters which are practically 383 
relevant, mitigation must be put in place to reduce the effect.   384 
The tolerances for the systematic shift in the gradient, the flow rate and the dwell volume in both 385 
the formic acid and ammonium formate DoE’s, and the pH of ammonium formate were all 386 
acceptable. Despite being deemed statistically significant, the practical relevance of the temperature 387 
limits in both DoE’s, and the % formic acid in both the aqueous and organic was negligible, thus the 388 
method for characterisation using formic acid can be considered robust within the stated limits. 389 
The concentration of acetonitrile in the B solvent for the ammonium formate gradient, however, has 390 
been shown to be a statistically significant result with practical implications. The decrease in 391 
concentration had ramifications on four of the six delta values, leading to the removal of the 392 
sensitive Δ(3,1), Δ(9,1) and Δ(10,9) probes from the characterisation. The removed delta values were 393 
probes for racemisation, which was still represented by Δ(9,1) and Δ(14,13) in formic acid. In 394 
addition, the integrity of the score plot was also assessed without the affected probes, with 395 
consistent results for the stationary phases.    396 
It is believed the robustness will actually be significantly better than shown in this study since the 397 
mitigations introduced (Table 7) will reduce variation further. The updated Peptide RPC Column 398 
Characterisation protocol is described in Appendix I. 399 
 400 
4 Conclusion 401 
The robustness of the Peptide RPC Column Characterisation protocol was assessed using reduced 402 
factorial design and PCA, with various factors systematically altered to deduce the impact on subtle 403 
changes to the protocol. The results indicate the formic acid gradient can be seen to provide robust 404 
results within the given tolerances of this study. The ammonium formate gradient, however, 405 
required mitigation to improve robustness in regards to the concentration of acetonitrile in the B 406 
solvent. All other parameters assessed did not influence the robustness.  407 
The sample load for the columns was also determined and the potential impact on switching 408 
between low and intermediate pH for certain commercially available stationary phases was 409 
evaluated. Both studies had ramifications for the protocol and mitigation was put in place to address 410 
both phenomena.  411 
In addition, the instrument variability on three different LC configurations and column batch to 412 
batch variability was assessed to ascertain the degree of variability which could be expected. Both 413 
the LC and column variability were minimal and highlights that the differences between stationary 414 
phases observed using the Peptide RPC Column Characterisation protocol are caused by 415 
chromatographic selectivity differences, rather than random error.  416 
A number of modifications were suggested in order to improve robustness, thus moving forward, 417 
the results should provide even greater reliability and reproducibility than shown in this study. This 418 
will offer greater confidence in characterising different stationary phases using peptides as probes 419 
and distinguishing their selectivity differences, thus allowing complementary stationary phases to be 420 
selected for method development or similar columns for back-up methods.  421 
 422 
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  428 
Appendix I: Description of the Peptide RPC Column Characterisation Protocol for 150 x 2.1 mm 429 
Column Formats  430 
If different column dimensions are employed, it is recommended that the user employs method translation tools [19]. 431 
Parameter Protocol 
Mobile Phase A1: 0.1% (±0.005%) v/v formic acid in water – Add 1.000 mL formic acid to 999.0 g (±0.01 g) water 
B1: 0.1% (±0.005%) v/v formic acid in acetonitrile – Add 1.000 mL formic acid to 785.2 g (±0.01 g) 
acetonitrile 
 A2: 20 mM Ammonium formate in water – Add 100.0 g (±0.01 g) 200 mM ammonium formate stock 
solution to 900.0 g (±0.01 g) water 
B2: Acetonitrile 
Stock Buffer 200 mM Ammonium formate pH 6.45 (±0.06) – Dissolve 1.261 g in 100.0 g (±0.01 g) water and 
measure the pH using an appropriately calibrated probe 
Gradient Time %B 
0.0 4.5 
40.0 50.0 
42.0 50.0 
42.1 4.5 
54.1 4.5 
 
Flow Rate 0.3 mL/min (±0.005 mL/min) 
Column Oven Temperature 40 °C (±2 °C) 
Autosampler Temperature Recommend 10 °C 
Wavelength 215 nm Ref 360 nm (band width 8 and 100 nm) 
MS Selected Ion Monitoring (z=2) 
Dwell Volume 100 – 500 µL 
Sample Concentration & 
Diluent 
0.25 mg/mL in DMSO/H2O (80:20 v/v) 
 432 
The run order is of great importance and should be first assessed at low pH then intermediate pH. 433 
Test 
Mixture 
Peptide 
Number 
Peptide Rationale m/z Load (µg) 
TM1 
1 Bovine GLP-2 (1-15) Original sequence 820 0.250 
8a [Met(O)10]-Bovine GLP-2 (1-15) Oxidation 828 0.250 
9 [L-Asp11]-Bovine GLP-2 (1-15) Deamidation / Negative charge 820 0.125 
13 Bovine GLP-2 (16-33) Original sequence 1069 0.250 
15 [Ile26,Leu27]-Bovine GLP-2 (16-33) Switch in AA sequence 1069 0.075 
TM2 
8a [Met(O10]-Bovine GLP-2 (1-15) Oxidation 828 0.250 
13 Bovine GLP-2 (16-33) Original sequence 1069 0.250 
15 [Ile26,Leu27]-Bovine GLP-2 (16-33) Switch in AA sequence 1069 0.075 
24 [Tyr26]-Bovine GLP-2 (16-33) Phenolic effect 1076 0.125 
26 [Lys26]-Bovine GLP-2 (16-33) Positive charge 1094 0.250 
TM3 
8a [Met(O)10]-Bovine GLP-2 (1-15) Oxidation 828 0.250 
13 Bovine GLP-2 (16-33) Original sequence 1069 0.250 
14 [D-Ser16]-Bovine GLP-2 (16-33) Racemisation 1069 0.125 
15 [Ile26,Leu27]-Bovine GLP-2 (16-33) Switch in AA sequence 1069 0.075 
16 [L-Asp21,Gly22]-Bovine GLP-2 (16-33) Loss of aromatic group / Racemisation 1024 0.125 
 434 
Test Mixture Delta Measured in Formic Acid Measured in Ammonium Formate 
TM1 
Δ(8a,1)   
Δ(9,1)   
Δ(15,13)   
TM2 
Δ(24,13)   
Δ(26,13)   
TM3 
Δ(14,13)   
Δ(16,13)   
 435 
 436 
  437 
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7 Figure Captions 527 
Fig. 1. Coefficient plots for each delta response for the different variables based on formic acid data.  528 
Fig. 2. Coefficient plots for each response for the different variables based on ammonium formate 529 
data. 530 
Fig. 3. A biplot of the columns used to develop the Peptide RPC Column Characterisation protocol in 531 
addition to the instrument variability (yellow triangles) and the robustness (light blue diamonds) 532 
results to assess the variability of the protocols using the 11 delta value responses.  533 
Fig. 4. Biplot of the batch to batch reproducibility performed on six Ascentis Express C18 columns on 534 
the reduced number of delta values, indicating the variability which could be expected between 535 
different batches of silica and silanes. Fig. 4 is mirrored in comparison to Fig. 3 due to one of the 536 
features of PCA where a very small difference in data often result in an axis being mirrored. The 537 
pattern and groupings are, however, the same in both figures. 538 
Fig. 5. Chromatograms demonstrating the effect of slow equilibration. (A) the original chromatogram 539 
in formic acid prior to exposure to ammonium formate at intermediate pH, (B) re-evaluation of the 540 
same column in formic acid after exposure to intermediate pH (C) re-evaluation after a static 541 
equilibration in formic acid to attempt to restore the original chromatography  542 
Fig. 6. Overlaid peak profile of the hydrophilic peptide [D-Asp3]-Bovine GLP-2 (1-15) of differing 543 
loads (0.031 – 2.000 µg) using the formic acid gradient conditions. The peak demonstrated the 544 
characteristic Langmuir’s isotherm with significant peak tailing with increased sample load 545 
Table 1 
The peptides used to calculate the delta values in (A) formic acid and (B) ammonium formate, with the accompanying rationale and typical Δtg and Δtg* for the Kinetex Evo 
C18 under the nominal conditions 
(A) 
Change Delta Peptide Number Peptide Rationale Δtg Δtg* 
[Met10] → [Met(O)10] Δ(8a,1) 
8a 
1 
[Met(O)10]-Bovine GLP-2 (1-15) 
[Met10]-Bovine GLP-2 (1-15) 
Oxidation -3.840 -0.286 
[L-Asn11] → [L-Asp11] Δ(9,1) 
9 
1 
[L-Asp11]-Bovine GLP-2 (1-15) 
[L-Asn11]-Bovine GLP-2 (1-15) 
Increase in negative charge 0.729 0.054 
[L-Ser16] → [D-Ser16] Δ(14,13) 
14 
13 
[D-Ser16]-Bovine GLP-2 (16-33) 
[L-Ser16]-Bovine GLP-2 (16-33) 
Steric - racemisation 0.171 0.013 
[Phe22] → [Gly22] Δ(16,13) 
16 
13 
[Gly22]-Bovine GLP-2 (16-33) 
[Phe22]-Bovine GLP-2 (16-33) 
Aromatic – removal of 
aromatic group 
-5.302 -0.395 
[Leu26] → [Lys26] Δ(26,13) 
26 
13 
[Lys26]-Bovine GLP-2 (16-33) 
[Leu26]-Bovine GLP-2 (16-33) 
Increase in positive charge -7.611 -0.566 
 
(B) 
Change Delta Peptide Number Peptide Rationale Δtg Δtg* 
[L-Asp3] → [D-Asp3] Δ(3,1) 
3 
1 
[D-Asp3]-Bovine GLP-2 (1-15) 
[L-Asp3]-Bovine GLP-2 (1-15) 
Steric - racemisation 0.064 0.003 
[L-Asn11] → [L-Asp11] Δ(9,1) 
9 
1 
[L-Asp11]-Bovine GLP-2 (1-15) 
[L-Asn11]-Bovine GLP-2 (1-15) 
Increase in negative charge 1.399 0.063 
[L-Asp11] → [D-Asp11] Δ(10,9) 
10 
9 
[D-Asp11]-Bovine GLP-2 (1-15) 
[L-Asp11]-Bovine GLP-2 (1-15) 
Steric - racemisation -0.581 -0.026 
[Leu26,Ile27] → [Ile26,Leu27] Δ(15,13) 
15 
13 
[Ile26,Leu27]-Bovine GLP-2 (16-33) 
[Leu26,Ile27]-Bovine GLP-2 (16-33) 
Steric – switch in amino 
acid sequence 
1.053 0.047 
[Leu26] → [Tyr26] Δ(24,13) 
24 
13 
[Tyr26]-Bovine GLP-2 (16-33) 
[Leu26]-Bovine GLP-2 (16-33) 
Aromatic and phenolic – 
addition of phenolic group 
-3.959 -0.179 
[Leu26] → [Lys26] Δ(26,13) 
26 
13 
[Lys26]-Bovine GLP-2 (16-33) 
[Leu26]-Bovine GLP-2 (16-33) 
Increase in positive charge -6.526 -0.295 
 
Table 2 
Peptide sequence of Bovine GLP-2 
 
Amino Acid # 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 
Bovine GLP-2 H A D G S F S D E M N T V L D S L A T R D F I N W L I Q T K I T D 
 
  
Table 3 
The peptide test mixtures, rationale and sample load 
Test 
Mixture 
Peptide 
Number 
Peptide Rationale Load (µg) 
TM1 
1 Bovine GLP-2 (1-15) Original sequence 0.250 
8a [Met(O)10]-Bovine GLP-2 (1-15) Oxidation 0.250 
9 [L-Asp11]-Bovine GLP-2 (1-15) Deamidation / Negative charge 0.125 
13 Bovine GLP-2 (16-33) Original sequence 0.250 
15 [Ile26,Leu27]-Bovine GLP-2 (16-33) Switch in AA sequence 0.075 
16 [L-Asp21,Gly22]-Bovine GLP-2 (16-33) Loss of aromatic group / Racemisation 0.125 
24 [Tyr26]-Bovine GLP-2 (16-33) Aromatic / Phenolic effect 0.125 
TM2 
8a [Met(O10]-Bovine GLP-2 (1-15) Oxidation 0.250 
9 [L-Asp11]-Bovine GLP-2 (1-15) Deamidation / Negative charge 0.125 
10 [D-Asp11]-Bovine GLP-2 (1-15) Deamidation / Racemisation / Negative charge 0.250 
13 Bovine GLP-2 (16-33) Original sequence 0.250 
15 [Ile26,Leu27]-Bovine GLP-2 (16-33) Switch in AA sequence 0.075 
26 [Lys26]-Bovine GLP-2 (16-33) Positive charge 0.250 
TM3 
1 Bovine GLP-2 (1-15) Original sequence 0.250 
3 [D-Asp3]-Bovine GLP-2 (1-15) Racemisation 0.125 
8a [Met(O)10]-Bovine GLP-2 (1-15) Oxidation 0.250 
13 Bovine GLP-2 (16-33) Original sequence 0.250 
14 [D-Ser16]-Bovine GLP-2 (16-33) Racemisation 0.125 
15 [Ile26,Leu27]-Bovine GLP-2 (16-33) Switch in AA sequence 0.075 
 
  
Table 4 
Operating parameters investigated in the DoE, including the nominal conditions (0 level) and the expected deviation (±1 levels) 
Parameter -1 Level 0 Level +1 Level 
Column Temperature (°C)1 38 40 42 
Flow Rate (mL/min)1 0.295 0.300 0.305 
Systematic Shift in Gradient (%B)1 -0.4 0.0 +0.4 
Dwell Volume (µL)1 100 300 500 
Volume Formic Acid in Aqueous (% v/v)2 0.095 0.100 0.105 
Volume Formic Acid in Organic (% v/v)2 0.095 0.100 0.105 
pH of Ammonium Formate3 6.39 6.45 6.51 
MeCN Composition in B (%)3 79.9 80.0 80.1 
1 Measured using both the formic acid and ammonium formate gradients 
2 Measured in just the formic acid gradient 
3 Measured in just the ammonium formate gradient 
 
  
Table 5 
The DoE design for the formic acid gradient, including the different experimental levels. N1-8 vary the ±1 levels whilst N9-11 are the nominal central conditions used to 
assess reproducibility 
Experiment 
Name 
Column 
Temperature 
(°C) 
Systematic 
Shift in 
Gradient (%B) 
Flow Rate 
(mL/min) 
Volume of Formic 
Acid in Aqueous 
(% v/v) 
Volume of Formic 
Acid in Organic  
(% v/v) 
Dwell Volume 
(µL) 
N1 - - - + + + 
N2 + - - - - + 
N3 - + - - + - 
N4 + + - + - - 
N5 - - + + - - 
N6 + - + - + - 
N7 - + + - - + 
N8 + + + + + + 
N9 0 0 0 0 0 0 
N10 0 0 0 0 0 0 
N11 0 0 0 0 0 0 
 
  
Table 6 
The DoE design for the ammonium formate gradient, including the different experimental levels. N1-8 vary the ±1 levels whilst N9-11 are the nominal central conditions 
used to assess reproducibility 
Experiment 
Name 
Column 
Temperature 
(°C) 
Systematic 
Shift in 
Gradient (%B) 
Flow Rate 
(mL/min) 
pH of Stock 
Ammonium 
Formate Solution 
MeCN 
Composition in B 
(%) 
Dwell Volume 
(µL) 
N1 - - - + + + 
N2 + - - - - + 
N3 - + - - + - 
N4 + + - + - - 
N5 - - + + - - 
N6 + - + - + - 
N7 - + + - - + 
N8 + + + + + + 
N9 0 0 0 0 0 0 
N10 0 0 0 0 0 0 
N11 0 0 0 0 0 0 
 
  
Table 7 
Mitigation to increase the robustness and reliability of the Peptide RPC Column Characterisation protocol, including the rationale for each action 
Mitigating Action Rationale 
Prepare solvents by weight rather than volume There are greater errors associated with glassware, thus more reproducible mobile phases can be 
prepared by weight. 
Assess the accuracy of the pipette before each use To ensure the pipette can accurately dispense formic acid. 
Measure the pH of the stock ammonium formate solution 
(6.39-6.51). 
The salt container should be carefully capped to avoid loss of ammonia which can result in a lower 
pH. In addition, measures should be put in place to reduce the effect of hygroscopicity (i.e. use a 
desiccator, avoid using salt which has significant clump formation). 
Use 100% MeCN instead of 20 mM ammonium formate in 
MeCN/H2O (80:20 w/w) in the B solvent combined with a 
corresponding change in gradient slope. 
The loss of acetonitrile in the B solvent causes significant differences for certain delta values. 
Changing to 100% MeCN addresses this problem. Even with the change in ammonium formate 
concentration, the results are still better with this change. 
Remove Δ(3,1), Δ(9,1) and Δ(10,9) measured in ammonium 
formate 
Improve the robustness of the procedure as they were sensitive to changes in MeCN. Although 
these delta values had some influence within the loading plot, they can be removed with minimal 
effect on the score plot and the remaining probes cover the range of interactions which should be 
investigated. 
Use reference peptides in each test mixture Allows retention times to be normalised for direct comparison between different batches of 
solvent, different analysts and removes the contribution from the dwell volume and column 
volume. 
Each test mixture should contain the two peptides used to 
create the delta value 
Removes any random injection to injection variation of retention time in addition to fluctuations in 
temperature or mobile phase composition. 
Characterise the stationary phase in formic acid prior to 
ammonium formate 
Removes the effect of slow equilibration and retention drifts. 
Use a specific load for each peptide Changing the load on the column can cause changes in retention which will impact on the delta 
value produced. 
Assess the actual temperature of the column Column oven designs can create as much as ±5 °C difference [35,36], which can impact significantly 
on selectivity. Obtaining the actual temperature of the oven enables the end-user to adjust the 
temperature appropriately for direct comparisons of different column oven designs. 
Solvent bottles should be stored correctly with a cap and 
stored at 5 °C. When stored on the system, a good vapour 
valve should be installed 
Storage of capped solvent bottles in the fridge reduces microbial growth and evaporation, whilst 
the vapour valve prevents dust / microbes entering the chromatographic system and acetonitrile 
losses.  
Reduce load of the peptides and add an inline filter to induce 
mixing and trapping of particles prior to column 
The hydrophobic peptides have a pI of 0.0 in ammonium formate at pH 6.45, which could cause 
solubility issues such as precipitation on the frit at the head of the column. This can cause bad peak 
shapes, increased pressures and reduced column lifetime. By reducing the load and introducing an 
inline filter, it will reduce the risk for precipitation and increase the robustness of the protocol. 
Use a reference column to act as a system suitability test This provides a baseline for the instrument to detect any differences in any asymmetrical shifts in 
the gradient (as well as other problems). 
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